<DOC>
	<DOCNO>NCT00290251</DOCNO>
	<brief_summary>This study evaluate whether experimental drug ulipristal acetate shrink uterine fibroid pre-menopausal woman .</brief_summary>
	<brief_title>Treatment Uterine Fibroids With Selective Progesterone Receptor Modulator CDB-2914</brief_title>
	<detailed_description>Uterine leiomyomata ( fibroid ) common benign tumor uterine muscle pre-menopausal woman may cause bleeding , pelvic pain pressure . Because fibroid grow presence estrogen , medical therapy decrease estrogen level ( like Gonadotropin release hormone , GnRH analog ) cause fibroid shrink may relieve symptom . However , medication give short-term inconvenient side effect hot-flashes . Thus , many woman symptomatic fibroid choose remove surgically , either individually remove uterus via hysterectomy . Women 25 50 year age regular menstrual cycle history uterine fibroid cause heavy bleeding , pressure , pain may eligible study . Candidates screen medical history physical examination , include breast pelvic examination , blood urine test , quality-of-life questionnaire , home urine test leuteinizing hormone ( LH ) surge . They give diary record LH surge , day vaginal spot bleeding , symptom . Participation include following : Baseline Studies ( First Menstrual Cycle ) - Magnetic resonance imaging ( MRI ) : The subject lie MRI scanner , narrow cylinder strong magnetic field , image uterus . - Saline hysterosonogram : This ultrasound examination uterus . A speculum place vagina small amount liquid insert uterus . A probe insert vagina . The probe emit receives sound wave use visualize fibroid surround structure . Study Drug Phase ( Second Fourth Menstrual Cycles ) - Subjects randomly assign take ulipristal acetate placebo ( inactive compound ) day mouth empty stomach three menstrual cycle 102 day menstrual cycle irregular stop . - Pregnancy test first second day every menstrual cycle . - Blood test every 2 week measure effect study medication hormone , blood count , blood chemistry liver function . - 24-hour urine collection three time study , month , measure cortisol check adrenal gland function . - Repeat transvaginal ultrasound 4-6 week study drug check fibroid growth . - Repeat hysterosonogram MRI within 2 week surgery count measure fibroid . placebo ( inactive compound ) day mouth empty stomach three menstrual cycle 102 day menstrual cycle irregular stop . - Pregnancy test first second day every menstrual cycle . - Blood test every 2 week measure effect study medication hormone , blood count , blood chemistry liver function . - 24-hour urine collection three time study , month , measure cortisol check adrenal gland function . - Repeat transvaginal ultrasound 4-6 week study drug check fibroid growth . - Repeat hysterosonogram MRI within 2 week surgery count measure fibroid . placebo ( inactive compound ) day mouth empty stomach three menstrual cycle 102 day menstrual cycle irregular stop . - Pregnancy test first second day every menstrual cycle . - Blood test every 2 week measure effect study medication hormone , blood count , blood chemistry liver function . - 24-hour urine collection three time study , month , measure cortisol check adrenal gland function . - Repeat transvaginal ultrasound 4-6 week study drug check fibroid growth . - Repeat hysterosonogram MRI within 2 week surgery count measure fibroid .</detailed_description>
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>INCLUSION CRITERIA : Female genderto evaluate effect target population clinical trial . History uterine leiomyoma cause symptom bleed , pressure , pain , define American College Obstetrics Gynecology ( ACOG ) practice bulletin : Excessive uterine bleeding evidence either followingprofuse bleed flood clot repetitive period last 8 day ; anemia due acute chronic blood loss ; OR Pelvic discomfort cause leiomyomata , either acute severe chronic low abdominal low back pressure bladder pressure urinary frequency due urinary tract infection . Uterine leiomyoma ( ta ) least 2 cm size . In good health . Chronic medication use acceptable except glucocorticoid use . Other chronic medication use may acceptable discretion research team . Interval use overthecounter drug acceptable must record . Menstrual cycle 24 35 day . Hemoglobin great 10 g/dL ( wish surgery ) ; iron may administer improve red blood cell count . Willing able comply study requirement . Age 25 50 . Using mechanical ( condom , diaphragm ) sterilization abstinence method contraception duration study . Negative urine pregnancy test . Body mass index ( BMI ) less equal 33 , surgical candidate less equal 35 , surgical candidate . Creatinine le 1.3 mg/dL . Liver function test within 130 % upper limit . If interested hysterectomy , desire fertility . EXCLUSION CRITERIA : Significant abnormality history , physical laboratory examination . Pregnancy . Lactation . Use oral , injectable inhaled glucocorticoid megestrol within last year . Unexplained vaginal bleeding . History malignancy within past 5 year . Use estrogen progesteronecontaining compound , oral contraceptive hormone replacement therapy , within 8 week study entry , include transdermal , injectable , vaginal oral preparation . Use agent know induce hepatic P450 enzyme ; use imidazole . Current use Gonadotropinreleasing hormone ( GnRH ) analogs compound affect menstrual cyclicity . Follicle stimulate hormone ( FSH ) great 20 IU/mL . Untreated cervical dysplasia . Need interval use narcotic . Abnormal adnexal/ovarian mass . Use herbal medication estrogenic antiestrogenic effect within past 3 month . Contradiction anesthesia , woman plan surgery . Genetic cause leiomyomata . Previous participation study . Known recent rapid growth fibroid , define double size six month .</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Endometrium</keyword>
	<keyword>Progesterone</keyword>
	<keyword>Estrogen</keyword>
	<keyword>Fibroid</keyword>
	<keyword>Hysterectomy</keyword>
	<keyword>Leiomyoma</keyword>
	<keyword>Uterine Fibroids</keyword>
	<keyword>Fibroids</keyword>
</DOC>